Abstract:Annexin 1 (ANXA1) is an endogenous anti-inflammatory protein implicated in cancer. ANXA1 was previously shown to be regulated by hsa-miR-196a. However, whether ANXA1 itself regulates microRNA (miR) expression is unknown. Therefore, we investigated the regulation of miR by ANXA1 in MCF7 breast cancer cells. MCF7-EV (Empty vector) and MCF7-V5 (ANXA1-V5 expressing cells) were subjected to a miR microarray. Microarray analysis revealed a number of miRNAs which were dysregulated in MCF7-V5 cells. 2 novel miRNAs (miR562 and miR26b*) were validated, cloned and functionally characterized. As ANXA1 constitutively activates NF-kB activity to modulate breast cancer metastasis, we found that miR26b* and miR562 directly targeted the canonical NF-kB pathway by targeting the 39 UTR and inhibiting expression of Rel A (p65) and NF-kB1 (p105) respectively. MiR562 inhibited wound healing, which was reversed when ANXA1 was overexpressed. Overexpression of either miR562 or miR26b* in MCF-7 cells enhanced endothelial tube formation when cocultured with human umbilical cord endothelial cells while conversely, treatment of MCF7 cells with either anti-miR562 or anti-miR26b* inhibited endothelial tube formation after co-culture. Further analysis of miR562 revealed that miR562-transfected cell conditioned media enhances endothelial cell tube formation, indicating that miR562 increased angiogenic secreted factors from MCF-7 breast tumor cells. TNFa was increased OPEN ACCESS Citation: Anbalagan D, Yap G, Yuan Y, Pandey VK, Lau WH, et al. (2014) Annexin-A1 Regulates MicroRNA-26b* and MicroRNA-562 to Directly Target NF-kB and Angiogenesis in Breast Cancer Cells. PLoS ONE 9(12): e114507. doi:10.1371/ journal.pone.0114507 Editor: Jun Li, Sun Yat-sen University Medical School, China Received: July 6, 2014 Accepted: November 8, 2014 Published: December 23, 2014 Copyright: 2014 Anbalagan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This grant was funded by A-Star (SIGN grant 07–11), Biomedical Research Council (BMRC 07/1/21/19/507) and Singapore National Kidney Foundation (NKFRC-2011/01/05) to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. PLOS ONE | DOI:10.1371/journal.pone.0114507 December 23, 2014 1 / 20 upon overexpression of miR562, which was reversed when ANXA1 was cotransfected In conclusion, this data suggests that ANXA1-regulated miR26b* and miR562 may play a role in wound healing and tumor-induced endothelial cell tube formation by targeting NF-kB expression and point towards a potential therapeutic target for breast cancer.

Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway

NKILA, a Prognostic Indicator, Inhibits Tumor Metastasis by Suppressing NF-κB/Slug Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

The Relationship of Lncrna NR2F1 and Breast Cancer Angiogenesis Via IL-8/lncRNA NR2F1/miR-200s/IL-8 Loop.

LncRNA NKILA Suppresses TGF‐β‐induced Epithelial–mesenchymal Transition by Blocking NF‐κB Signaling in Breast Cancer

Long Non-Coding Rna Nkila Inhibits Migration And Invasion Of Tongue Squamous Cell Carcinoma Cells Via Suppressing Epithelial-Mesenchymal Transition

Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway

NF-kappa B interacting long noncoding RNA enhances the Warburg effect and angiogenesis and is associated with decreased survival of patients with gliomas

Lncrna Nr2f1-As1 Promotes Breast Cancer Angiogenesis Through Activating Igf-1/Igf-1r/Erk Pathway

TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling

NKILA Represses Nasopharyngeal Carcinoma Carcinogenesis and Metastasis by NF-κB Pathway Inhibition.

A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis.

Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p

NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

LncRNA NKILA correlates with the malignant status and serves as a tumor-suppressive role in rectal cancer

The Long Noncoding RNA NKILA Protects Against Myocardial Ischaemic Injury by Enhancing Myocardin Expression Via Suppressing the NF-κB Signalling Pathway.

Expression Level and Clinical Significance of NKILA in Human Cancers: A Systematic Review and Meta-Analysis

Annexin-A 1 Regulates MicroRNA-26 b * and MicroRNA-562 to Directly Target NFk B and Angiogenesis in Breast Cancer Cells

Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling

LncRNA HOTAIR promotes cell migration and invasion by regulating MKL1 via inhibition miR206 expression in HeLa cells

NKILA is a novel suppressor of local recurrence in women breast malignant phyllodes tumor patients via inhibition of the NF-κB pathway

LINC00460 Promotes Angiogenesis by Enhancing NF-κB-mediated VEGFA Expression in Cervical Cancer Cells